Do the new PCPT findings make you less likely to recommend finasteride for PCa?

Share this article:

After 18 months of follow-up of patients in the Prostate Cancer Prevention Trial (PCPT), Ian M. Thompson, Jr. MD, and colleagues found that finasteride decreased the risk of prostate cancer (PCa) by about a one third, but it had no effect on overall survival or survival after the diagnosis of PCa, according to a report in the New England Journal of Medicine (2013;369:603-610). 

In an editorial accompanying the report, Michael LeFevre, MD, wrote that the safest conclusion one can draw about the use of finasteride for PCa prevention “is that it has no short- or long-term effect on all-cause mortality, so we cannot recommend its use to prolong life.” 

Renal & Urology News invites urologists to answer the following online poll question.


Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

During your career, have you ever rendered in-flight medical assistance?

During your career, have you ever rendered in-flight ...

It is inevitable that some passengers will become ill during a flight.

How do you feel about on-call emergency department coverage?

How do you feel about on-call emergency department ...

The nation's community hospitals are facing increasing problems obtaining emergency on-call coverage.

Have you ever recommended acupuncture to a patient?

Have you ever recommended acupuncture to a patient?

Evidence suggests acupuncture may help ease certain types of pain and perhaps other conditions